{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:30:16Z","timestamp":1791329416329,"version":"4.3.1"},"reference-count":38,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"accepted":{"date-parts":[[1997,9,23]]},"published-print":{"date-parts":[[1998,3,1]]},"abstract":"<jats:p>\n                    <jats:italic>Background<\/jats:italic>\n                    \u2014Arylamine\n                    <jats:italic>N<\/jats:italic>\n                    -acetyltransferases in humans (NAT1 and NAT2) catalyse the acetylation of arylamines including food derived heterocyclic arylamine carcinogens. Other substrates include the sulphonamide 5-aminosalicylic acid (5-ASA), which is an NAT1 specific substrate;\n                    <jats:italic>N<\/jats:italic>\n                    -acetylation of 5-ASA is a major route of metabolism. NAT1 and NAT2 are both polymorphic.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Aims<\/jats:italic>\n                    \u2014To investigate NAT expression in apparently healthy human intestines in order to understand the possible role of NAT in colorectal cancer and in the therapeutic response to 5-ASA.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Methods<\/jats:italic>\n                    \u2014The intestines of four organ donors were divided into eight sections. DNA was prepared for genotyping\n                    <jats:italic>NAT1<\/jats:italic>\n                    and\n                    <jats:italic>NAT2<\/jats:italic>\n                    and enzymic activities of NAT1 and\n                    <jats:italic>NAT2<\/jats:italic>\n                    were determined in cytosols prepared from each section. Tissue was fixed for immunohistochemistry with specific NAT antibodies. Western blotting was carried out on all samples of cytosol and on homogenates of separated muscle and villi after microdissection.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results<\/jats:italic>\n                    \u2014NAT1 activity of all cytosols was greater than NAT2 activity. NAT1 and NAT2 activities correlated with the genotypes of\n                    <jats:italic>NAT1<\/jats:italic>\n                    and\n                    <jats:italic>NAT2<\/jats:italic>\n                    and with the levels of NAT1 staining determined by western blotting. The ratio of NAT1:NAT2 activities showed interindividual variations from 2 to 70. NAT1 antigenic activity was greater in villi than in muscle. NAT1 was detected along the length of the villi in the small intestine. In colon samples there was less NAT1 at the base of the crypts with intense staining at the tips.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions<\/jats:italic>\n                    \u2014The interindividual variation in NAT1 and NAT2 in the colon could affect how individuals respond to exposure to specific NAT substrates including carcinogens and 5-ASA.\n                  <\/jats:p>","DOI":"10.1136\/gut.42.3.402","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T12:46:12Z","timestamp":1277901972000},"page":"402-409","source":"Crossref","is-referenced-by-count":121,"title":["Expression of arylamine\n                    <i>N<\/i>\n                    -acetyltransferase in human intestine"],"prefix":"10.1136","volume":"42","author":[{"given":"D","family":"Hickman","sequence":"first","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pope","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S D","family":"Patil","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Fakis","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Smelt","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L A","family":"Stanley","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Payton","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Unadkat","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Sim","sequence":"additional","affiliation":[{"name":"aDepartment of Pharmaceutics, University of Washington, Seattle, Washington, USA, \n\nbDepartment of Pharmacology, University of Oxford, Oxford, UK, \n\ncDepartment of Pharmaceutical Sciences, De Montfort University, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1998,3,1]]},"reference":[{"key":"2025120601071103000_42.3.402.1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0031-6997(25)06816-4","article-title":"N-acetyltransferase pharmacogenetics.","volume":"37","author":"Weber","year":"1985","journal-title":"Pharmacol Rev"},{"key":"2025120601071103000_42.3.402.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9525(00)89162-3"},{"key":"2025120601071103000_42.3.402.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540180050032"},{"key":"2025120601071103000_42.3.402.4","doi-asserted-by":"publisher","DOI":"10.1038\/369154a0"},{"key":"2025120601071103000_42.3.402.5","first-page":"35","article-title":"Role of acetylation in colorectal cancer.","volume":"290","author":"Minchin","year":"1993","journal-title":"Mutat Res"},{"key":"2025120601071103000_42.3.402.6","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(85)90004-7"},{"key":"2025120601071103000_42.3.402.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.37513.x"},{"key":"2025120601071103000_42.3.402.8","unstructured":"Josephy PD (1997) Molecular toxicology. (Oxford University Press, New York), pp 352\u2013363."},{"key":"2025120601071103000_42.3.402.9","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1172\/JCI105306","article-title":"Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid.","volume":"44","author":"Jenne","year":"1965","journal-title":"J Clin Invest"},{"key":"2025120601071103000_42.3.402.10","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199502000-00001"},{"key":"2025120601071103000_42.3.402.11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijc.2910460107","article-title":"Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations.","volume":"46","author":"Wohlleb","year":"1990","journal-title":"Int J Cancer"},{"key":"2025120601071103000_42.3.402.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91886-4"},{"key":"2025120601071103000_42.3.402.13","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.2.231"},{"key":"2025120601071103000_42.3.402.14","first-page":"3537","article-title":"Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.","volume":"55","author":"Bell","year":"1995","journal-title":"Cancer Res"},{"key":"2025120601071103000_42.3.402.15","first-page":"2017","article-title":"Acetylation polymorphism and prevalence of colorectal adenomas.","volume":"55","author":"Probst-Hensch","year":"1995","journal-title":"Cancer Res"},{"key":"2025120601071103000_42.3.402.16","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/17.10.2125"},{"key":"2025120601071103000_42.3.402.17","first-page":"5226","article-title":"Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue.","volume":"55","author":"Bell","year":"1995","journal-title":"Cancer Res"},{"key":"2025120601071103000_42.3.402.18","unstructured":"Payton MA, Sim E. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of a novel mutation. Biochem Pharmacol (in press). ."},{"key":"2025120601071103000_42.3.402.19","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.2.229"},{"key":"2025120601071103000_42.3.402.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(97)00026-2"},{"key":"2025120601071103000_42.3.402.21","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90493-6"},{"key":"2025120601071103000_42.3.402.22","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/6.2.251"},{"key":"2025120601071103000_42.3.402.23","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.8.1633"},{"key":"2025120601071103000_42.3.402.24","doi-asserted-by":"publisher","DOI":"10.1159\/000134601"},{"key":"2025120601071103000_42.3.402.25","first-page":"1803","article-title":"Detailed physical and deletion map of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer.","volume":"12","author":"Farrington","year":"1996","journal-title":"Oncogene"},{"key":"2025120601071103000_42.3.402.26","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/8.1.133"},{"key":"2025120601071103000_42.3.402.27","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00182-Y"},{"key":"2025120601071103000_42.3.402.28","doi-asserted-by":"publisher","DOI":"10.1177\/44.9.8773572"},{"key":"2025120601071103000_42.3.402.29","unstructured":"Hickman D Chandrasena G Unadkat JD (1995) Longitudinal distribution of arylamine N-acetyltransferases along the human small intestine. 4th International Society for the Study of Xenobiotics (ISSX) Meeting; 1995 Aug 27\u201331; Seattle. (ISSX, Seattle), p 250."},{"key":"2025120601071103000_42.3.402.30","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1016\/S0021-9258(19)38219-5","article-title":"Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.","volume":"265","author":"Deguchi","year":"1990","journal-title":"J Biol Chem"},{"key":"2025120601071103000_42.3.402.31","doi-asserted-by":"crossref","unstructured":"Hickman D, Chandrasena G, Patil SD, et al. Arylamine N-acetyltransferase activities in human liver and intestine. 8th Japanese-American Conference on Pharmacokinetics and Pharmaceutics; 1996 July 28\u201330; Seattle. Japanese-American Conference on Pharmacokinetics, 1996:28. .","DOI":"10.2165\/00003088-199630010-00003"},{"key":"2025120601071103000_42.3.402.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(96)00567-9"},{"key":"2025120601071103000_42.3.402.33","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199704000-00005"},{"key":"2025120601071103000_42.3.402.34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0090-9556(25)08199-1","article-title":"Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57Bl\/6J Rapid and B6.ANats slow acetylator congenic mice.","volume":"21","author":"Chung","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"2025120601071103000_42.3.402.35","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/tx960082y","article-title":"Effects of heredity on response to drugs and environmental chemicals: construction of rodent models.","volume":"9","author":"Levy","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"2025120601071103000_42.3.402.36","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711720405"},{"key":"2025120601071103000_42.3.402.37","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(89)90018-3"},{"key":"2025120601071103000_42.3.402.38","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.6.761"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.42.3.402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T09:07:20Z","timestamp":1765012040000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.42.3.402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3,1]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1998,3,1]]},"published-print":{"date-parts":[[1998,3,1]]}},"alternative-id":["10.1136\/gut.42.3.402"],"URL":"https:\/\/doi.org\/10.1136\/gut.42.3.402","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3,1]]}}}